tiprankstipranks
Trending News
More News >
TME Pharma N.V. (DE:0N6A)
FRANKFURT:0N6A
Germany Market

TME Pharma N.V. (0N6A) Ratios

Compare
0 Followers

TME Pharma N.V. Ratios

DE:0N6A's free cash flow for Q2 2024 was €0.00. For the 2024 fiscal year, DE:0N6A's free cash flow was decreased by € and operating cash flow was €0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
0.78 0.78 1.84 3.63 0.45
Quick Ratio
0.77 0.77 1.82 3.58 0.42
Cash Ratio
0.72 0.72 1.80 3.56 0.40
Solvency Ratio
-2.31 -2.31 -2.73 -3.50 -0.23
Operating Cash Flow Ratio
-1.88 -1.88 -2.35 -1.80 -1.22
Short-Term Operating Cash Flow Coverage
-3.11 -3.11 -5.12 -9.57 9.44
Net Current Asset Value
€ -2.00M€ -1.50M€ 4.43M€ 7.57M€ -2.00M
Leverage Ratios
Debt-to-Assets Ratio
0.78 0.78 0.25 <0.01 0.07
Debt-to-Equity Ratio
-3.21 -3.21 0.54 <0.01 -0.06
Debt-to-Capital Ratio
1.45 1.45 0.35 <0.01 -0.07
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 >-0.01
Financial Leverage Ratio
-4.12 -4.12 2.16 1.38 -0.94
Debt Service Coverage Ratio
-1.59 -1.59 -3.28 -1.02 1.80
Interest Coverage Ratio
-3.54 -3.54 -8.82 -1.14 -1.32K
Debt to Market Cap
2.47 2.47 0.14 0.03 -0.06
Interest Debt Per Share
5.77 5.77 5.42 14.35 0.95
Net Debt to EBITDA
1.57 0.05 0.54 1.94 1.57
Profitability Margins
Gross Profit Margin
0.00%0.00%-199900.00%-179900.00%-668081.82%
EBIT Margin
0.00%0.00%-39236363.64%-15288571.43%-556493.51%
EBITDA Margin
0.00%0.00%-39036363.64%-15108571.43%-525974.03%
Operating Profit Margin
0.00%0.00%-40203030.30%-16482857.14%-2563636.36%
Pretax Profit Margin
0.00%0.00%-43793939.39%-29731428.57%-558441.56%
Net Profit Margin
0.00%0.00%-43793939.39%-29728571.43%-559090.91%
Continuous Operations Profit Margin
0.00%0.00%-43796969.70%-29731428.57%-559090.91%
Net Income Per EBT
100.04%100.04%100.00%99.99%100.12%
EBT Per EBIT
125.75%125.75%108.93%180.38%21.78%
Return on Assets (ROA)
-49.71%-288.72%-147.95%-97.66%-49.71%
Return on Equity (ROE)
46.72%1189.62%-320.09%-134.95%46.72%
Return on Capital Employed (ROCE)
223.05%998.26%-294.69%-74.37%223.05%
Return on Invested Capital (ROIC)
181.39%-427.67%-191.13%-71.85%181.39%
Return on Tangible Assets
-49.83%-288.94%-148.01%-97.70%-49.83%
Earnings Yield
-12.02%-955.75%-84.84%-51.86%-12.02%
Efficiency Ratios
Receivables Turnover
0.00 0.00 <0.01 <0.01 <0.01
Payables Turnover
0.05 0.05 0.03 0.03 0.86
Inventory Turnover
1.24 1.24 0.53 0.42 9.44
Fixed Asset Turnover
0.00 0.00 <0.01 <0.01 <0.01
Asset Turnover
0.00 0.00 <0.01 <0.01 <0.01
Working Capital Turnover Ratio
0.00 0.00 <0.01 <0.01 >-0.01
Cash Conversion Cycle
186.85K -6.43K 884.23K 709.99K 186.85K
Days of Sales Outstanding
187.24K 0.00 895.91K 719.57K 187.24K
Days of Inventory Outstanding
38.66 293.59 685.76 863.25 38.66
Days of Payables Outstanding
424.24 6.72K 12.36K 10.45K 424.24
Operating Cycle
187.28K 293.59 896.59K 720.43K 187.28K
Cash Flow Ratios
Operating Cash Flow Per Share
-9.36 -9.36 -17.01 -14.63 -34.82
Free Cash Flow Per Share
-9.37 -9.37 -17.03 -14.74 -34.95
CapEx Per Share
0.02 0.02 0.02 0.11 0.13
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
-578.24 -578.24 -884.36 -133.95 -267.88
Capital Expenditure Coverage Ratio
-578.24 -578.24 -884.36 -133.95 -267.88
Operating Cash Flow Coverage Ratio
-2.97 -2.97 -5.07 -75.71 -37.60
Operating Cash Flow to Sales Ratio
0.00 0.00 -375.18K -149.26K -27.83K
Free Cash Flow Yield
-60.05%-768.29%-72.77%-26.23%-60.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.10 -0.10 -1.18 -1.93 -8.32
Price-to-Sales (P/S) Ratio
0.00 0.00 516.17K 573.20K 46.52K
Price-to-Book (P/B) Ratio
-1.24 -1.24 3.77 2.60 -3.89
Price-to-Free Cash Flow (P/FCF) Ratio
-0.13 -0.13 -1.37 -3.81 -1.67
Price-to-Operating Cash Flow Ratio
-0.13 -0.13 -1.38 -3.84 -1.67
Price-to-Earnings Growth (PEG) Ratio
<0.01 <0.01 0.04 >-0.01 0.09
Price-to-Fair Value
-1.24 -1.24 3.77 2.60 -3.89
Enterprise Value Multiple
-0.09 -0.09 -0.78 -1.86 -7.28
Enterprise Value
5.89M 1.04M 10.02M 9.83M 5.89M
EV to EBITDA
-7.28 -0.09 -0.78 -1.86 -7.28
EV to Sales
38.27K 0.00 303.57K 280.77K 38.27K
EV to Free Cash Flow
-1.37 -0.09 -0.81 -1.87 -1.37
EV to Operating Cash Flow
-1.37 -0.09 -0.81 -1.88 -1.37
Tangible Book Value Per Share
-0.98 -0.98 6.18 21.55 -15.09
Shareholders’ Equity Per Share
-0.98 -0.98 6.20 21.60 -14.97
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 >-0.01 -0.04 >-0.01
Revenue Per Share
0.00 0.00 <0.01 <0.01 <0.01
Net Income Per Share
-11.66 -11.66 -19.85 -29.15 -6.99
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.00 1.29 1.12 1.94 1.00
Research & Development to Revenue
3.22K 0.00 322.94K 114.77K 3.22K
SG&A to Revenue
8.57K 0.00 38.33K 26.06K 8.57K
Stock-Based Compensation to Revenue
694.81 0.00 14.39K 4.63K 694.81
Income Quality
4.98 0.80 0.86 0.50 4.98
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis